Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2006 1
2007 2
2008 2
2009 6
2010 12
2011 12
2012 10
2013 14
2014 15
2015 11
2016 9
2017 14
2018 11
2019 9
2020 16
2021 27
2022 25
2023 12
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial.
Mulatero P, Wuerzner G, Groessl M, Sconfienza E, Damianaki A, Forestiero V, Vogt B, Brunner H, Gerlock T, Steele R, Schumacher C. Mulatero P, et al. Among authors: wuerzner g. EClinicalMedicine. 2024 Apr 6;71:102576. doi: 10.1016/j.eclinm.2024.102576. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38618204 Free PMC article.
Association of serum copeptin and urinary uromodulin with kidney function, blood pressure and albuminuria at 6 weeks post-partum in pre-eclampsia.
Jaques DA, Dufey Teso A, Wuerzner G, Martinez De Tejada B, Santagata M, Othenin Girard V, Le Tinier B, Pechere Bertschi A, Ponte B. Jaques DA, et al. Among authors: wuerzner g. Front Cardiovasc Med. 2024 Mar 4;11:1310300. doi: 10.3389/fcvm.2024.1310300. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38500759 Free PMC article.
Lateral medullary vascular compression manifesting as paroxysmal hypertension.
Giammattei L, Wuerzner G, Theiler K, Vollenweider P, Dunet V, Al Barajraji M, Squair JW, Bloch J, Daniel RT. Giammattei L, et al. Among authors: wuerzner g. Acta Neurochir (Wien). 2024 Mar 15;166(1):139. doi: 10.1007/s00701-024-06032-y. Acta Neurochir (Wien). 2024. PMID: 38488893 Free PMC article.
The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study.
Bandiera C, Dotta-Celio J, Locatelli I, Nobre D, Wuerzner G, Pruijm M, Lamine F, Burnier M, Zanchi A, Schneider MP. Bandiera C, et al. Among authors: wuerzner g. Front Pharmacol. 2024 Jan 24;15:1294436. doi: 10.3389/fphar.2024.1294436. eCollection 2024. Front Pharmacol. 2024. PMID: 38327981 Free PMC article.
[Hypertension: what's new in 2023].
Wuerzner G, Ponte B, Pechere-Bertschi A. Wuerzner G, et al. Rev Med Suisse. 2024 Jan 31;20(859):252-254. doi: 10.53738/REVMED.2024.20.859.252. Rev Med Suisse. 2024. PMID: 38299956 French.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
203 results